Research centre for pharmaceutical care and pharmaco-economics, faculty of pharmaceutical sciences, K.U. Leuven, Herestraat 49, O&N 2, PB 521, 3000 Leuven, Belgium.
Eur Psychiatry. 2012 Oct;27(7):528-35. doi: 10.1016/j.eurpsy.2010.12.009. Epub 2011 Mar 9.
The aim of the present study was to measure stigma among community pharmacists regarding patients with depression, using social distance as a proxy measure. Furthermore, factors influencing stigmatization were identified.
A survey consisting of questions regarding social distance, cognitive attitude components, stereotypical beliefs and behavioural tendencies towards pharmaceutical care for patients with depression was carried out. The survey was completed by 149 community pharmacists with a response rate of 82%. Multiple linear regression analysis was applied to the results of the survey.
Most pharmacists endorsed social distance towards patients with depression. The social distance further increased the more the situation described implied "social closeness". Age, depression care attitude, the stereotypical belief "danger to others" and the level of involvement pharmacists showed towards patients with depression were found to predict social distance. The present model explains 32.3% of the variance in social distance.
The results showed that community pharmacists have a stigmatizing attitude towards patients with depression. The determinants found to influence these stigmatizing attitudes might be addressed when trying to reduce stigmatization of patients with depression.
本研究旨在通过使用社会距离作为替代指标，来衡量社区药剂师对抑郁症患者的污名化程度。此外，还确定了影响污名化的因素。
调查采用了一系列问题，涉及社区药剂师对抑郁症患者的社会距离、认知态度成分、刻板印象信念以及药物治疗行为倾向。共有 149 名社区药剂师参与了调查，回应率为 82%。对调查结果进行了多元线性回归分析。
大多数药剂师对抑郁症患者表示出社会距离。描述的情况越暗示“社会亲近”，社会距离就会进一步增加。年龄、抑郁护理态度、刻板印象信念“对他人的危险”以及药剂师对抑郁症患者的参与程度被发现可以预测社会距离。本模型解释了社会距离变化的 32.3%。
结果表明，社区药剂师对抑郁症患者存在污名化态度。当试图减少对抑郁症患者的污名化时，可能需要解决这些污名化态度的决定因素。
